Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000950170-24-137938

Chief Financial Officer bought 7,716 shares at an average $4.76 ($36,726)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levine James E. Chief Financial Officer 2024-12-16 Purchase +2,564 $3.83 $9,820 62,564 I
Levine James E. Chief Financial Officer 2024-12-17 Purchase +2,752 $5.42 $14,905 65,316 I
Levine James E. Chief Financial Officer 2024-12-18 Purchase +2,400 $5.00 $12,000 67,716 I
Open-market purchases · 7,716 sh · avg $4.76 · $36,726
Loading xslF345X05/ownership.xml…